Centers | ||
|
|
|
UCSC Chemical Screening Center | FDA Oncology Center of Excellence Project Catalyst | BLAVATNIK CENTER for Drug Discovery |
We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of... |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under... Read more |
Partnerships |
Events |
Jobs |
Vanderbilt Enters Into Collaboration With BMS to Develop Drugs to treat Parkinsons DiseaseVanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Bristol-Myers Squibb Company have entered into a broad collaboration agreement to co-develop new drugs to treat Parkinsons Disease. Under the collaboration agreement VCNDD will identify... View all Sanofi and UCSF Establish Two Research Collaboration ProgramsSanofi has established two collaboration programs with University of California, San Francisco (UCSF). One collaboration pertains exclusively to oncology while the second one covers multiple therapeutic areas including oncology, inflammation,... View all The Division of Signal Transduction TherapyA vital asset of the MRC-PPU is the Division of Signal Transduction Therapy (DSTT) which was established in 1998. This division operates as a unique collaboration between scientists in the MRC-PPU (all PIs including Ronald Hay FRS Honorary PI of... View all |
No EVENTS for listing |
No Job Posts |
